Differential effect of soluble fibrinogen as a neutrophil activator

Microvascular Research

Volumn 83, Issue 3, 2012, Pages 332-336

  de Almeida, V Vitorino ^a   Calado, A ^a   Rosario H S ^a   Saldanha, C ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FIBRINOGEN; FIBRINOGEN RECEPTOR;

ARTICLE; BINDING SITE; CELL ACTIVATION; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION;

CELL SURVIVAL; ENDOTHELIAL CELLS; FIBRINOGEN; FLOW CYTOMETRY; FREE RADICALS; HUMANS; INFLAMMATION; LEUKOCYTE ROLLING; MACROPHAGE-1 ANTIGEN; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEUTROPHIL ACTIVATION; NEUTROPHILS; OXYGEN;

EID: 84859481767     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.02.001     Document Type: Article

References (6)

1. Flick M.J., Xinli D., Degen J.L. Fibrin(ogen)-alphaMbeta2 interactions regulate leukocyte function and innate immunity in vivo. Exp. Biol. Med. 2004, 229:1105-1110.
2. Flick M.J., Du X., Witte D.P., Jirousková M., Soloviev D.A., Busuttil S.J., et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor aMb2/Mac-1 is critical for host inflammatory respose in vivo. J. Clin. Investig. 2004, 113(11):1596-1606.
3. Henderson L., Chappell J. Dihydrorhodamine 123: a fluorescent probe for superoxide generation?. Eur. J. Biochem. 1993, 217(3):973-980.
4. Kakafika A., Liberopoulos E., Mikhailidis D. Fibrinogen: a predictor of vascular disease. Curr. Pharm. Des. 2007, 13(16):1647-1659.
5. Kamath S., Lip G. Fibrinogen: biochemistry, epidemiology and determinants. Q. J. Med. 2003, 96(10):711-729.
6. 2 (MAC-1). J. Biol. Chem. 2004, 279(43):44897-44906.